ADMA Biologics Inc (NAS:ADMA)
$ 17.67 0.26 (1.49%) Market Cap: 4.12 Bil Enterprise Value: 4.14 Bil PE Ratio: 62.18 PB Ratio: 17.75 GF Score: 68/100

Q2 2024 ADMA Biologics Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: $12.19 (+6.46%)
Operator

Good afternoon, and welcome to the ADMA. biologics Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call.

At this time, I would like to introduce Skyler Bloom. Please go ahead.

Skyler Bloom ADMA Biologics Inc;Senior Director
Business Development and Corporate Strategy

Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics financial results for the second quarter of 2024 and recent corporate updates. IĆ¢m joined today by Adam Grossman, President, Chief Executive Officer; and Brad Tade, Chief Financial Officer and Treasurer.

During todayĆ¢s call, Adam will provide some introductory comments and provide an update on corporate progress, and then Brad will provide an overview of the companyĆ¢s second quarter 2024 financial results. Finally, Adam will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot